Related references
Note: Only part of the references are listed.Characterization of the Neurochemical and Behavioral Effects of Solriamfetol (JZP-110), a Selective Dopamine and Norepinephrine Reuptake Inhibitor
Michelle G. Baladi et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2018)
Effect of psychostimulants on blood pressure profile and endothelial function in narcolepsy
Adriana Bosco et al.
NEUROLOGY (2018)
SOLRIAMFETOL (JZP-110) FOR TREATMENT OF EXCESSIVE SLEEPINESS IN NARCOLEPTIC PATIENTS WITH AND WITHOUT CATAPLEXY: RESULTS FROM A RANDOMIZED, PHASE 3, CLINICAL TRIAL
Y. Dauvilliers et al.
SLEEP (2018)
SOLRIAMFETOL (JZP-110) FOR TREATMENT OF EXCESSIVE SLEEPINESS IN NARCOLEPTIC PATIENTS WITH AND WITHOUT CATAPLEXY: RESULTS FROM A RANDOMIZED, PHASE 3, CLINICAL TRIAL
Y. Dauvilliers et al.
SLEEP (2018)
Listening to the Patient Voice in Narcolepsy: Diagnostic Delay, Disease Burden, and Treatment Efficacy
Kiran Maski et al.
JOURNAL OF CLINICAL SLEEP MEDICINE (2017)
Correlation between the Epworth Sleepiness Scale and the Maintenance of Wakefulness Test in patients with narcolepsy participating in two clinical trials of sodium oxybate
Milton Erman et al.
SLEEP MEDICINE (2017)
The European Medicines Agency review of pitolisant for treatment of narcolepsy: summary of the scientific assessment by the Committee for Medicinal Products for Human Use
Marta Kollb-Sielecka et al.
SLEEP MEDICINE (2017)
Effect of Oral JZP-110 (ADX-N05) on Wakefulness and Sleepiness in Adults with Narcolepsy: A Phase 2b Study
Chad Ruoff et al.
SLEEP (2016)
Effect of Oral JZP-110 (ADX-N05) on Wakefulness and Sleepiness in Adults with Narcolepsy: A Phase 2b Study
Chad Ruoff et al.
SLEEP (2016)
Clinical and practical considerations in the pharmacologic management of narcolepsy
Michael J. Thorpy et al.
SLEEP MEDICINE (2015)
Effect of oral JZP-110 (ADX-N05) treatment on wakefulness and sleepiness in adults with narcolepsy
Richard K. Bogan et al.
SLEEP MEDICINE (2015)
Car Crashes and Central Disorders of Hypersomnolence: A French Study
Fabio Pizza et al.
PLOS ONE (2015)
The Burden of Narcolepsy Disease (BOND) study: health-care utilization and cost findings
Jed Black et al.
SLEEP MEDICINE (2014)
Pitolisant versus placebo or modafinil in patients with narcolepsy: a double-blind, randomised trial
Yves Dauvilliers et al.
LANCET NEUROLOGY (2013)
Modafinil as a catecholaminergic agent: empirical evidence and unanswered questions
Jonathan Wisor
FRONTIERS IN NEUROLOGY (2013)
The burden of narcolepsy with cataplexy: How disease history and clinical features influence socio-economic outcomes
Francesca Ingravallo et al.
SLEEP MEDICINE (2012)
The Columbia-Suicide Severity Rating Scale: Initial Validity and Internal Consistency Findings From Three Multisite Studies With Adolescents and Adults
Kelly Posner et al.
AMERICAN JOURNAL OF PSYCHIATRY (2011)
Sleep disorders, medical conditions, and road accident risk
Michael H. Smolensky et al.
ACCIDENT ANALYSIS AND PREVENTION (2011)
How to Keep the Brain Awake? The Complex Molecular Pharmacogenetics of Wake Promotion
Sibah Hasan et al.
NEUROPSYCHOPHARMACOLOGY (2009)
Health-related quality of life in patients with narcolepsy
Richard Dodel et al.
SLEEP MEDICINE (2007)
Sodium oxybate improves excessive daytime sleepiness in narcolepsy
Jed Black et al.
SLEEP (2006)
The efficacy and safety of armodafinil as treatment for adults with excessive sleepiness associated with narcolepsy
John R. Harsh et al.
CURRENT MEDICAL RESEARCH AND OPINION (2006)
Practice Parameters for clinical use of the multiple sleep latency test and the maintenance of wakefulness test - An American Academy of Sleep Medicine Report - Standards of practice committee of the American Academy of Sleep Medicine
MR Littner et al.
SLEEP (2005)
Dosing regimen effects of modafinil for improving daytime wakefulness in patients with narcolepsy
JRL Schwartz et al.
CLINICAL NEUROPHARMACOLOGY (2003)
A randomized trial of the long-term, continued efficacy and safety of modafinil in narcolepsy
H. Moldofsky et al.
SLEEP MEDICINE (2000)
Narcolepsy: genetic predisposition and neuropharmacological mechanisms
S Nishino et al.
SLEEP MEDICINE REVIEWS (2000)